Casatest vivo

In vivo tests - UB-CARE ITALY

Por um escritor misterioso
Last updated 02 junho 2024
In vivo tests - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
Laboratory - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
In vivo tests - UB-CARE ITALY
Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy
In vivo tests - UB-CARE ITALY
In vitro safety - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging
In vivo tests - UB-CARE ITALY
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
In vivo tests - UB-CARE ITALY
Pancreatic β-cell mitophagy as an adaptive response to metabolic stress and the underlying mechanism that involves lysosomal Ca2+ release
In vivo tests - UB-CARE ITALY
Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
In vivo tests - UB-CARE ITALY
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
In vivo tests - UB-CARE ITALY
Laboratory - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
UB-CARE - Sperimentazioni in vitro, analisi, biosafety
In vivo tests - UB-CARE ITALY
Identification of druggable regulators of cell secretion via a kinome-wide screen and high-throughput immunomagnetic cell sorting
In vivo tests - UB-CARE ITALY
Pharmaceutics, Free Full-Text
Recomendado para você
você pode gostar

© 2014-2024 rahh.de. All rights reserved.